Alzheimer’s/Dementia

Home/Disease Specific/Alzheimer's/Dementia

Sleep deprivation accelerates Alzheimer’s brain damage

Poor sleep has long been linked with Alzheimer’s disease, but researchers have understood little about how sleep disruptions drive the disease. Now, studying mice and people, researchers at Washington University School of Medicine in St. Louis have found that sleep deprivation increases levels of the key Alzheimer’s protein tau. And, in follow-up studies in the

Racial differences in Alzheimer’s disease unveiled

African-Americans may be twice as likely as Caucasian Americans to develop Alzheimer’s disease, but nobody knows why because studies investigating the underlying causes of illness have historically drawn from a nearly all-white pool of research participants. Consequently, little is known about how the neurodegenerative disease arises and progresses in people of non-Caucasian backgrounds. Now, a

January 15th, 2019|Categories: Alzheimer's/Dementia, Around The State|

Alzheimer’s researchers receive Chan Zuckerberg Initiative funding

A team of researchers at Washington University School of Medicine in St. Louis has been funded by the Chan Zuckerberg Initiative (CZI)to study the root causes of neurodegenerative disorders. The project at the School of Medicine will analyze genes that may help protect some patients from Alzheimer’s disease. The researchers suspect that certain variants in TREM2 and another

Historic breakthrough: WVU Rockefeller Neuroscience team first to use ultrasound to treat Alzheimer’s

World-leading brain experts at West Virginia University’s Rockefeller Neuroscience Institute are celebrating the historic breakthrough Alzheimer patients around the global have been waiting for. “For Alzheimer’s, there’s not that many treatments available despite hundreds of clinical trials over the past two decades and billions of dollars spent,” said Dr. Ali R. Rezai, a neurosurgeon at

November 20th, 2018|Categories: Alzheimer's/Dementia, Disease Specific|

Cardiovascular disease, Alzheimer’s genetically linked

Studying DNA from more than 1.5 million people, an international team of researchers — led by Washington University School of Medicine in St. Louis and the University of California, San Francisco — has identified points of DNA that increase the risk of cardiovascular disease and also heighten the risk for Alzheimer’s disease. Scientists have long

Alzheimer’s one day may be predicted during eye exam

It may be possible in the future to screen patients for Alzheimer’s disease using an eye exam. Using technology similar to what is found in many eye doctors’ offices, researchers at Washington University School of Medicine in St. Louis have detected evidence suggesting Alzheimer’s in older patients who had no symptoms of the disease. Their

A promising drug to slow the progression of Alzheimer’s was just unveiled

Alzheimer’s is one of the deadliest, costliest, and most emotionally draining diseases in this country. Yet we have no drugs to reverse the condition, and the last medicine that came on the market to treat Alzheimer’s symptoms was approved some 15 years ago. So it’s no surprise that Alzheimer’s researchers, patients, and investors were eagerly anticipating the results of

July 30th, 2018|Categories: Alzheimer's/Dementia, Disease Specific|